More clinical studies with herbal medicines: A requirement for the future

Planta Medica ◽  
2009 ◽  
Vol 75 (09) ◽  
Author(s):  
N Armbruester
2009 ◽  
Vol 30 (S 01) ◽  
Author(s):  
J Grünwald ◽  
N Armbrüster ◽  
H Stier

Toxins ◽  
2021 ◽  
Vol 13 (2) ◽  
pp. 145
Author(s):  
Su-In Hwang ◽  
Young-Jin Yoon ◽  
Soo-Hyun Sung ◽  
Ki-Tae Ha ◽  
Jang-Kyung Park

Animal toxins and venoms have recently been developed as cancer treatments possessing tumor cell growth-inhibitory, antiangiogenesis, and proapoptotic effects. Endometriosis is a common benign gynecological disorder in reproductive-age women, and no definite treatment for this disorder is without severe side effects. As endometriosis and malignant tumors share similar characteristics (progressive, invasive, estrogen-dependent growth, and recurrence), animal toxins and venoms are thought to be effective against endometriosis. The objective of this study was to outline studies using toxic animal-based medicinal materials (TMM) as endometriosis treatment and to explore its clinical applicability. Preclinical and clinical studies using TMM were searched for in four databases from inception to October 2020. A total of 20 studies of TMM on endometriosis were included. In eight clinical studies, herbal medicines containing TMM were effective in relieving symptoms of endometriosis, with no side effects. In twelve experimental studies, the main therapeutic mechanisms of TMM against endometriosis were proapoptotic, antiangiogenesis, estrogen level-reducing, and possible anti-inflammatory effects. TMM are thus considered promising sources for the development of an effective treatment method for endometriosis. Further studies are needed to clarify the therapeutic mechanism of TMM against endometriosis and to provide sufficient grounds for clinical application.


ESC CardioMed ◽  
2018 ◽  
pp. 3111-3114
Author(s):  
Thomas Münzel ◽  
Sanjay Rajagopalan ◽  
Mette Sørenson ◽  
Dave Newby ◽  
Robert D. Brook

For the future, well-designed sustainable prevention strategies are needed, based on the results of preclinical and clinical studies across sectors such as transport, housing, and energy in order to accomplish multiple gains for health, climate, and the environment.


2013 ◽  
Vol 2013 ◽  
pp. 1-15 ◽  
Author(s):  
Shu-Yi Yin ◽  
Wen-Chi Wei ◽  
Feng-Yin Jian ◽  
Ning-Sun Yang

Medicinal herbs and their derivative phytocompounds are being increasingly recognized as useful complementary treatments for cancer. A large volume of clinical studies have reported the beneficial effects of herbal medicines on the survival, immune modulation, and quality of life (QOL) of cancer patients, when these herbal medicines are used in combination with conventional therapeutics. Here, we briefly review some examples of clinical studies that investigated the use of herbal medicines for various cancers and the development of randomized controlled trials (RCTs) in this emerging research area. In addition, we also report recent studies on the biochemical and cellular mechanisms of herbal medicines in specific tumor microenvironments and the potential application of specific phytochemicals in cell-based cancer vaccine systems. This review should provide useful technological support for evidence-based application of herbal medicines in cancer therapy.


Horticulturae ◽  
2021 ◽  
Vol 7 (12) ◽  
pp. 523
Author(s):  
Riccardo Motti ◽  
Bruna de Falco

Anxiety and insomnia are among the most common mental health disorders and are a major cause of disability around the world. Traditional herbal medicines are receiving significant attention in global health debates. Several Italian regions maintain rural traditions and are among the most extensively studied areas of Europe regarding medicinal plant uses. The present overview aims to highlight the use of wild and cultivated plants, specifically as sedatives and for insomnia treatment in Italy, and to collect, analyze, and summarize the available literature about their pharmacological activity as well as clinical and pre-clinical studies concerning the most cited plants. In total, 106 wild taxa are used in Italy for sedative purposes. The plant species belong to 76 genera and 32 families, of which the most cited are Asteraceae (24.2%) and Lamiaceae (21.1%). Leaves (29%) and flowers (27%) are the plant parts mostly used as infusion (70%) and decoction (25%). Out of 106 taxa documented, only the most cited are analyzed in this overview (A. arvensis L., C. nepeta L., C. monogyna Jacq., H. lupulus L., L. nobilis L., L. angustifolia Mill., M. sylvestris L., M. chamomilla L., M. officinalis L., O. basilicum L., P. rhoeas L., P. somniferum L., R. officinalis L., T. platyphyllus Scop., and V. officinalis L.). Among the fifteen species selected, only seven have been studied for their pharmacological activity as hypnotic-sedatives. Future pre-clinical and clinical studies are needed to better clarify the mechanism of action of bioactive compounds and confirm the potential of these alternative therapies.


2018 ◽  
Vol 38 (3) ◽  
pp. 379-392
Author(s):  
Kazuyoshi ISHIDA ◽  
Satoshi YAMASHITA ◽  
Tomoyuki MORIOKA ◽  
Shunsuke KAWANAMI ◽  
Atsuo YAMASHITA ◽  
...  

2021 ◽  
Vol 2021 ◽  
pp. 1-6
Author(s):  
Koichi Yuki ◽  
James A. DiNardo ◽  
Sophia Koutsogiannaki

Perioperative bleeding is one of the major comorbidities associated with surgery. While anesthesia is a critical component to perform surgery, a number of clinical studies supported the contribution of anesthetic drugs to perioperative bleeding. Here, we reviewed the literature on this topic including the underlying mechanism and discussed the future direction on coagulation research in anesthesia.


Sign in / Sign up

Export Citation Format

Share Document